在儿科文献中对撤回的特征,模式和原因进行了全面的图书统计分析
Dina Essam Abo-Elnour1, Mohamed Mohsen Helal2, Abdulrahman Ahmed Albalasy3
1Faculty of Medicine, Zagazig University, Zagazig, Egypt. dinaessam750@gmail.com.
European journal of pediatrics
|November 8, 2025
概括
收回的儿科研究正在增加,大多数病例与来自亚洲的不当行为有关. 需要更严格的指导方针来确保儿科的科学完整性.
科学领域:
- 儿科研究 儿科研究
- 图书统计学 图书统计学
- 科学完整性 科学完整性
背景情况:
- 生物医学研究中的撤回正在增加,通常是由于不当行为.
- 儿科研究的撤回正在增加,但仍未得到充分探索.
- 这项研究提供了全面分析收回的儿科出版物.
研究的目的:
- 系统地确定收回的儿科用品的特点.
- 探索从1995年到2024年的儿科研究撤回的模式和原因.
- 强调需要改善儿科研究中的完整性措施.
主要方法:
- 搜索了PubMed和Retraction Watch数据库,寻找被撤回的儿科出版物.
- 从590件独特的收缩件中提取了数据.
- 对收缩因子进行了统计分析和相关性矩阵.
主要成果:
- 大多数撤回 (73.4%) 来自亚洲,主要是中国.
- 研究不当行为 (37.5%) 是撤回的主要原因.
- 收回时间与期刊影响因子和引用正相关.
结论:
- 收回的儿科论文的增加表明了一个需要注意的关键问题.
- 研究人员和出版商必须实施强有力的法规,以提高科学诚信.
- 需要采取紧急措施来提高儿科研究的质量和可信度.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
197
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
234
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Regression Toward the Mean
6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


